As of 2024-12-15, the Relative Valuation of CellaVision AB (CEVI.ST) is 203.94 SEK. This relative valuation is based on P/E multiples. With the latest stock price at 226.50 SEK, the upside of CellaVision AB based on Relative Valuation is -10.0%.
The range of the Relative Valuation is 173.08 - 217.61 SEK.
| Range | Selected | |
| Trailing P/E multiples | 27.5x - 33.9x | 30.9x |
| Forward P/E multiples | 33.1x - 35.6x | 34.8x |
| Fair Price | 173.08 - 217.61 | 203.94 |
| Upside | -23.6% - -3.9% | -10.0% |
| Date | P/E |
| 2024-12-12 | 35.72 |
| 2024-12-11 | 35.88 |
| 2024-12-10 | 34.85 |
| 2024-12-09 | 34.45 |
| 2024-12-06 | 33.03 |
| 2024-12-05 | 33.50 |
| 2024-12-04 | 33.66 |
| 2024-12-03 | 33.98 |
| 2024-12-02 | 34.14 |
| 2024-11-29 | 34.69 |
| 2024-11-28 | 35.57 |
| 2024-11-27 | 35.17 |
| 2024-11-26 | 34.06 |
| 2024-11-25 | 35.17 |
| 2024-11-22 | 34.45 |
| 2024-11-21 | 34.06 |
| 2024-11-20 | 33.58 |
| 2024-11-19 | 34.77 |
| 2024-11-18 | 35.72 |
| 2024-11-15 | 37.31 |
| 2024-11-14 | 36.99 |
| 2024-11-13 | 37.95 |
| 2024-11-12 | 38.50 |
| 2024-11-11 | 38.42 |
| 2024-11-08 | 38.58 |
| 2024-11-07 | 38.90 |
| 2024-11-06 | 38.34 |
| 2024-11-05 | 38.03 |
| 2024-11-04 | 37.95 |
| 2024-11-01 | 36.68 |
| 2024-10-31 | 36.99 |
| 2024-10-30 | 38.11 |
| 2024-10-29 | 39.14 |
| 2024-10-28 | 40.73 |
| 2024-10-25 | 41.36 |
| 2024-10-24 | 44.38 |
| 2024-10-23 | 43.74 |
| 2024-10-22 | 43.82 |
| 2024-10-21 | 44.30 |
| 2024-10-18 | 44.77 |
| 2024-10-17 | 43.90 |
| 2024-10-16 | 44.77 |
| 2024-10-15 | 46.12 |
| 2024-10-14 | 46.52 |
| 2024-10-11 | 45.81 |
| 2024-10-10 | 46.44 |
| 2024-10-09 | 46.20 |
| 2024-10-08 | 45.09 |
| 2024-10-07 | 45.09 |
| 2024-10-04 | 47.08 |